Bristol-Myers Squibb Company (BMY) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Bristol-Myers Squibb Company's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Investment Score:
44/100
Fair
Valuation Metrics
P/E Ratio
-12.81
Weak
WeakModerateStrong
P/B Ratio
7.02
Strong
WeakModerateStrong
Earnings Yield
-7.80%
Weak
WeakModerateStrong
Profitability Health
Return on Equity
-54.78%
Weak
WeakModerateStrong
Operating Margin
20.00%
Moderate
WeakModerateStrong
Net Profit Margin
-18.53%
Weak
WeakModerateStrong
Growth Indicators
Revenue Growth
7.32%
Moderate
WeakModerateStrong
Net Income Growth
-211.50%
Weak
WeakModerateStrong
EPS Growth
-213.66%
Weak
WeakModerateStrong
Efficiency & Liquidity
Current Ratio
1.25
Moderate
WeakModerateStrong
Quick Ratio
1.15
Moderate
WeakModerateStrong
Asset Turnover
0.52x
Moderate
WeakModerateStrong
Inventory Turnover
8.16x
Strong
WeakModerateStrong